{"version":"1.0","type":"link","title":"Transcriptome-guided drug repurposing identifies selumetinib for an aggressive epithelial cancer.","author_name":"Dorfer S 외","author_url":"https://prs-insight.online/author/Dorfer%20S","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/169558","thumbnail_width":1200,"thumbnail_height":630}